Skip to main content
$72.59 -$0.25 (-0.3%)

04:00 PM EDT on 06/02/23

AstraZeneca plc (ADR) (NASDAQ:AZN)

CAPS Rating: 3 out of 5

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Current Price $72.59 Mkt Cap $225.0B
Open $72.92 P/E Ratio 47.80
Prev. Close $72.59 Div. (Yield) $1.45 (2.0%)
Daily Range $72.57 - $73.42 Volume 8,040,709
52-Wk Range $52.65 - $76.56 Avg. Daily Vol. 4,126,699

Caps

How do you think NASDAQ:AZN will perform against the market?

Add Stock to CAPS Watchlist

All Players

745 Outperform
39 Underperform
 

All-Star Players

136 Outperform
6 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:AZN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFkodyk123 (34.14)
Submitted July 20, 2021

AstraZeneca is primed to expand its presence within the huge and growing orphan drug market, expand its market share in China's oncology market via its new indication for Imfinzi, and the stock is trading at a discount to fair value.

KingPortu (95.25)
Submitted October 29, 2007

I like the MedImmune acquisition but their balance sheet looks like crap- 5billion in cash vs 15billion in debt, plus negative earnings and revenue. Think it will take some time before the MedImmune acquisition starts to pay off

Recent Community Commentary

Read the most recent pitches from players about AZN.

Recs

1
Member Avatar TMFkodyk123 (34.14) Submitted: 7/19/2021 8:32:50 PM : Outperform Start Price: $54.70 NASDAQ:AZN Score: +32.41

AstraZeneca is primed to expand its presence within the huge and growing orphan drug market, expand its market share in China's oncology market via its new indication for Imfinzi, and the stock is trading at a discount to fair value.

Recs

1
Member Avatar RCi (60.84) Submitted: 1/10/2021 2:53:36 PM : Outperform Start Price: $49.48 NASDAQ:AZN Score: +33.97

Revenue growth and Profit margins.

Recs

1
Member Avatar XMFZhiyuanSun (< 20) Submitted: 9/13/2020 8:41:06 PM : Outperform Start Price: $49.48 NASDAQ:AZN Score: +34.41

Promising COVID-19 vaccine in development by EoY.

Leaderboard

Find the members with the highest scoring picks in AZN.

Score Leader

timjake

timjake (25.84) Score: +386.57

The Score Leader is the player with the highest score across all their picks in AZN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
timjake 25.84 3/17/2008 Outperform NS $9.84 +639.18% +252.61% +386.57 1 Comment
equalfuture 24.63 3/18/2008 Outperform 1Y $10.16 +616.50% +241.69% +374.81 1 Comment
snickers4niki 73.88 3/28/2008 Outperform NS $10.31 +605.57% +233.93% +371.65 0 Comment
oferm 36.25 3/19/2008 Outperform 3W $10.35 +603.10% +232.71% +370.39 0 Comment
gallo19 75.63 3/14/2008 Outperform NS $10.26 +609.43% +244.20% +365.23 0 Comment
IMakeItRain 88.29 3/14/2008 Outperform 3Y $10.39 +600.62% +236.14% +364.48 0 Comment
Ramhorn < 20 3/14/2008 Outperform NS $10.39 +600.62% +236.14% +364.48 0 Comment
b400 99.31 3/5/2008 Outperform 5Y $10.46 +595.74% +232.76% +362.99 0 Comment
floridabull33 85.73 3/27/2008 Outperform 3M $10.48 +594.43% +233.09% +361.34 1 Comment
EpicAhab 32.91 2/12/2008 Outperform 5Y $10.57 +588.34% +230.81% +357.52 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for AZN.